DK1033988T3 - Parenterale formuleringer indeholdende 10-hydroxy-10,11-tetrahydrocarbamazepin, vand og glucose - Google Patents

Parenterale formuleringer indeholdende 10-hydroxy-10,11-tetrahydrocarbamazepin, vand og glucose

Info

Publication number
DK1033988T3
DK1033988T3 DK98950110T DK98950110T DK1033988T3 DK 1033988 T3 DK1033988 T3 DK 1033988T3 DK 98950110 T DK98950110 T DK 98950110T DK 98950110 T DK98950110 T DK 98950110T DK 1033988 T3 DK1033988 T3 DK 1033988T3
Authority
DK
Denmark
Prior art keywords
tetrahydrocarbamazepine
glucose
hydroxy
water
formulations containing
Prior art date
Application number
DK98950110T
Other languages
Danish (da)
English (en)
Inventor
Hoogevest Peter Van
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1033988T3 publication Critical patent/DK1033988T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK98950110T 1997-10-09 1998-10-07 Parenterale formuleringer indeholdende 10-hydroxy-10,11-tetrahydrocarbamazepin, vand og glucose DK1033988T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (1)

Publication Number Publication Date
DK1033988T3 true DK1033988T3 (da) 2004-04-13

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98950110T DK1033988T3 (da) 1997-10-09 1998-10-07 Parenterale formuleringer indeholdende 10-hydroxy-10,11-tetrahydrocarbamazepin, vand og glucose

Country Status (32)

Country Link
US (2) US6316417B1 (es)
EP (1) EP1033988B1 (es)
JP (2) JP2001519395A (es)
KR (1) KR100760326B1 (es)
CN (1) CN1210032C (es)
AR (1) AR015465A1 (es)
AT (1) ATE257383T1 (es)
AU (1) AU748034B2 (es)
BR (1) BR9812861A (es)
CA (1) CA2304661C (es)
CO (2) CO4950520A1 (es)
CZ (1) CZ298900B6 (es)
DE (1) DE69821024T2 (es)
DK (1) DK1033988T3 (es)
ES (1) ES2214738T3 (es)
GB (1) GB9721497D0 (es)
HK (1) HK1031824A1 (es)
HU (1) HU226106B1 (es)
ID (1) ID24134A (es)
IL (1) IL135123A0 (es)
MY (1) MY122129A (es)
NO (1) NO327263B1 (es)
NZ (1) NZ503526A (es)
PE (1) PE121998A1 (es)
PL (1) PL192287B1 (es)
PT (1) PT1033988E (es)
RU (1) RU2242231C2 (es)
SK (1) SK286253B6 (es)
TR (1) TR200000870T2 (es)
TW (1) TW584563B (es)
WO (1) WO1999018966A1 (es)
ZA (1) ZA989183B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
NZ567290A (en) * 2005-09-30 2011-08-26 Lundbeck Inc Carbamazepine-cyclodextrin complex for parenteral administration
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0435825T3 (da) * 1989-12-27 1996-02-12 Ciba Geigy Ag Apparat til homogenisering af den inhomogene lysfordeling i et laserstrålelysbundt
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
HU226106B1 (en) 2008-04-28
EP1033988B1 (en) 2004-01-07
KR100760326B1 (ko) 2007-09-20
ES2214738T3 (es) 2004-09-16
US6316417B1 (en) 2001-11-13
CO5090854A1 (es) 2001-10-30
EP1033988A1 (en) 2000-09-13
HK1031824A1 (en) 2001-06-29
PT1033988E (pt) 2004-05-31
GB9721497D0 (en) 1997-12-10
JP2001519395A (ja) 2001-10-23
TW584563B (en) 2004-04-21
US6458770B1 (en) 2002-10-01
NO20001730D0 (no) 2000-04-04
WO1999018966A1 (en) 1999-04-22
RU2242231C2 (ru) 2004-12-20
CZ20001279A3 (cs) 2000-07-12
SK5052000A3 (en) 2000-12-11
CO4950520A1 (es) 2000-09-01
NO20001730L (no) 2000-04-04
PL339446A1 (en) 2000-12-18
IL135123A0 (en) 2001-05-20
JP2005281314A (ja) 2005-10-13
SK286253B6 (sk) 2008-06-06
TR200000870T2 (tr) 2000-10-23
AR015465A1 (es) 2001-05-02
DE69821024D1 (de) 2004-02-12
ATE257383T1 (de) 2004-01-15
ID24134A (id) 2000-07-06
AU9629898A (en) 1999-05-03
CN1210032C (zh) 2005-07-13
CA2304661A1 (en) 1999-04-22
AU748034B2 (en) 2002-05-30
DE69821024T2 (de) 2004-10-28
HUP0004362A2 (hu) 2001-08-28
BR9812861A (pt) 2000-08-08
NZ503526A (en) 2003-01-31
KR20010072533A (ko) 2001-07-31
CN1274286A (zh) 2000-11-22
HUP0004362A3 (en) 2006-06-28
CA2304661C (en) 2007-12-11
US20020055503A1 (en) 2002-05-09
PL192287B1 (pl) 2006-09-29
MY122129A (en) 2006-03-31
PE121998A1 (es) 1999-12-08
NO327263B1 (no) 2009-05-25
ZA989183B (en) 1999-04-09
CZ298900B6 (cs) 2008-03-05

Similar Documents

Publication Publication Date Title
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE69917403T8 (de) Glukose-sensor
DE69923308D1 (de) Stuhlstruktur
DE69826554D1 (de) Lehnstuhl
NO20000057L (no) Kjernerør
FI980221A (fi) Refraktometri
NO20003916L (no) Benzotiadiazoler og derivater
NO20013237L (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
ATE239030T1 (de) Kohlenhydrat-derivate
TR199801781A3 (tr) Sapkali tarak.
DE69800992T2 (de) Fritiergerät
DK1033988T3 (da) Parenterale formuleringer indeholdende 10-hydroxy-10,11-tetrahydrocarbamazepin, vand og glucose
EE200000650A (et) Kihisevad preparaadid
DK0888962T3 (da) Fremdrivningsenhed
TR199700354A3 (tr) Karbohidrat türevleri.
FR2763498B1 (fr) Endoscope, en particulier mediastinoscope
ID19498A (id) Sorben selektif oksigen
ID19573A (id) Herbisida selektif berbasiskan
DE69926933D1 (de) Verbinderstruktur
SI1033988T1 (en) Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose
DE69803820D1 (de) Silberhalogenidemulsion
GB0005108D0 (en) Glucose responsive -cell line
ATE238672T1 (de) Fermentation-toleranter vorteig
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
DK1127052T3 (da) Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf